Company intelligence / Profile preview

HGB

Phnom Penh, Cambodia

Ownership: Private
Development stage: Other

Overview

HGB is a diversified investment and management group with a significant presence in the healthcare and pharmaceutical sectors, particularly within the Southeast Asian market. The company focuses on the distribution, marketing, and retail of pharmaceutical products, medical devices, and healthcare services. HGB operates through various subsidiaries to provide comprehensive supply chain solutions and healthcare infrastructure. Their business model integrates logistics with specialized healthcare delivery to improve access to medical treatments in emerging markets. The group is known for its strategic partnerships with international pharmaceutical manufacturers to bring advanced therapies to the region.

Industry: Investors

Beyond the preview

Go deeper on HGB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HGB.

Explore the full profile